A carregar...

Brain metastases in ALK-positive NSCLC – time to adjust current treatment algorithms

The progress in molecular biology has revolutionized systemic treatment of advanced non-small-cell lung cancer (NSCLC) from conventional chemotherapy to a treatment stratified by histology and genetic aberrations. Tumors harboring a translocation of the anaplastic-lymphoma-kinase (ALK) gene constitu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Griesinger, Frank, Roeper, Julia, Pöttgen, Christoph, Willborn, Kay C., Eberhardt, Wilfried E.E.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205553/
https://ncbi.nlm.nih.gov/pubmed/30416687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26073
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!